General Motors Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

General Motors Investment Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-833	Closed	-$376K	–	496
2015 Q1	$376K	Sell	833 -35	-4%	-$14.8K	0.03%	614
2014 Q4	$356K	Buy	868 +198	+30%	+$77.9K	0.03%	617
2014 Q3	$242K	Sell	670 -653	-49%	-$219K	0.02%	750
2014 Q2	$374K	Buy	+1,323	New	+$392K	0.03%	579
2013 Q4	–	Sell	-704	Closed	-$220K	–	988
2013 Q3	$220K	Buy	+704	New	+$185K	0.02%	777

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

General Motors Investment Management's REGN Position: Q2 2015 in Review

General Motors Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2015, closing a stake of 833 shares — an estimated $376K sold.

General Motors Investment Management first reported a position in REGN in Q3 2013 and held it in 5 quarters. The position peaked at $376K in Q1 2015. 541 funds tracked by Wall St. Rank hold REGN as of Q2 2015.

General Motors Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
General Motors Investment Management sold 833 Regeneron Pharmaceuticals shares in Q2 2015, an estimated $376K.
General Motors Investment Management first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 5 quarters.
General Motors Investment Management's Regeneron Pharmaceuticals position peaked at $376K in Q1 2015.
541 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2015.

Based on General Motors Investment Management's 13F filing for Q2 2015, filed 5 Aug 2015.